
‘MAHA Report' calls for fighting chronic disease, but Trump and Kennedy have yanked funding
Yet in its feverish purge of federal health programs, it has proposed eliminating the National Center for Chronic Disease Prevention and Health Promotion and its annual funding of $1.4 billion.
That's one of many disconnects between what the administration says about health — notably, in the 'MAHA Report' that President Donald Trump recently presented at the White House — and what it's actually doing, scientists and public health advocates say.
Among other contradictions:
The report says more research is needed on health-related topics such as chronic diseases and the cumulative effects of chemicals in the environment. But the Trump administration's mass cancellation of federal research grants to scientists at universities, including Harvard, has derailed studies on those subjects.
The report denounces industry-funded research on chemicals and health as widespread and unreliable. But the administration is seeking to cut government funding that could serve as a counterweight.
The report calls for 'fearless gold-standard science.' But the administration has sowed widespread fear in the scientific world that it is out to stifle or skew research that challenges its desired conclusions.
'There are many inconsistencies between rhetoric and action,' said Alonzo Plough, chief science officer at the Robert Wood Johnson Foundation, a philanthropy focused on health.
The report, a cornerstone of President Donald Trump's 'Make America Healthy Again' agenda, was issued by a commission that includes Secretary of Health and Human Services Robert F. Kennedy Jr. and other top administration officials.
News organizations found that it footnoted nonexistent sources and contained signs that it was produced with help from artificial intelligence. White House Press Secretary Karoline Leavitt described the problems as 'formatting issues,' and the administration revised the report.
Trump ordered the report to assess causes of a 'childhood chronic disease crisis.' His commission is now working on a plan of action.
Spokespeople for the White House and Department of Health and Human Services did not respond to questions for this article.
The MAHA report says environmental chemicals may pose risks to children's health. Citing the National Institutes of Health, it said there's a 'need for continued studies from the public and private sectors, especially the NIH, to better understand the cumulative load of multiple exposures and how it may impact children's health.'
Meanwhile, the administration has cut funding for related studies.
For example, in 2020 the Environmental Protection Agency asked scientists to propose ways of researching children's exposure to chemicals from soil and dust. It said that, for kids ages 6 months to 6 years, ingesting particulates — by putting their hands on the ground or floor then in their mouths — could be a significant means of exposure to contaminants such as herbicides, pesticides, and a group of chemicals known as PFAS.
One of the grants — for almost $1.4 million over several years — went to a team of scientists at Johns Hopkins University and the University of California-San Francisco. Researchers gained permission to collect samples from people's homes, including dust and diapers.
But, beyond a small test run, they didn't get to analyze the urine and stool samples because the grant was terminated this spring, said study leader Keeve Nachman, a professor of environmental health and engineering at Hopkins.
'The objectives of the award are no longer consistent with EPA funding priorities,' the agency said in a May 10 termination notice.
Another EPA solicitation from 2020 addressed many of the issues the MAHA report highlighted: cumulative exposures to chemicals and developmental problems such as attention-deficit/hyperactivity disorder, obesity, anxiety, and depression. One of the resulting grants funded the Center for Early Life Exposures and Neurotoxicity at the University of North Carolina-Chapel Hill. That grant was ended weeks early in May, said the center's director, Stephanie Engel, a UNC professor of epidemiology.
In a statement, EPA press secretary Brigit Hirsch said the agency 'is continuing to invest in research and labs to advance the mission of protecting human health and the environment.' Due to an agency reorganization, 'the way these grants are administered will be different going forward,' said Hirsch, who did not otherwise answer questions about specific grants.
In its battle with Harvard, the Trump administration has stopped paying for research the NIH had commissioned on topics such as how autism might be related to paternal exposure to air pollution.
The loss of millions of dollars of NIH funding has also undermined data-gathering for long-term research on chronic diseases, Harvard researchers said. A series of projects with names like Nurses' Health Study II and Nurses' Health Study 3 have been tracking thousands of people for decades and aimed to keep tracking them as long as possible as well as enrolling new participants, even across generations.
The work has included periodically surveying participants — mainly nurses and other health professionals who enrolled to support science — and collecting biological samples such as blood, urine, stool, or toenail clippings.
Researchers studying health problems such as autism, ADHD, or cancer could tap the data and samples to trace potential contributing factors, said Francine Laden, an environmental epidemiologist at Harvard's T.H. Chan School of Public Health. The information could retrospectively reveal exposures before people were born — when they were still in utero — and exposures their parents experienced before they were conceived.
Harvard expected that some of the grants wouldn't be renewed, but the Trump administration brought ongoing funding to an abrupt end, said Walter Willett, a professor of epidemiology and nutrition at the Chan school.
As a result, researchers are scrambling to find money to keep following more than 200,000 people who enrolled in studies beginning in the 1980s — including children of participants who are now adults themselves — and to preserve about 2 million samples, Willett said.
'So now our ability to do exactly what the administration wants to do is jeopardized,' said Jorge Chavarro, a professor of nutrition and epidemiology at the Chan school. 'And there's not an equivalent resource. It's not like you can magically recreate these resources without having to wait 20 or 30 years to be able to answer the questions' that the Trump administration 'wants answered now.'
Over the past few months, the administration has fired or pushed out almost 5,000 NIH employees, blocked almost $3 billion in grant funding from being awarded, and terminated almost 2,500 grants totaling almost $5 billion, said Sen. Patty Murray (D-Wash.), vice chair of the Senate Appropriations Committee, at a June 10 hearing on the NIH budget.
In addition, research institutions have been waiting months to receive money under grants they've already been awarded, Murray said.
In canceling hundreds of grants with race, gender, or sexuality dimensions, the administration engaged in blatant discrimination, a federal judge ruled on June 16.
After issuing the MAHA report, the administration published budget proposals to cut funding for the NIH by $17.0 billion, or 38%, the Centers for Disease Control and Prevention by $550 million, or 12%, and the EPA by $5 billion, or 54%.
'This budget reflects the President's vision of making Americans the healthiest in the world while achieving his goal of transforming the bureaucracy,' the HHS 'Budget in Brief' document says. Elements of Trump's proposed budget for the 2026 fiscal year clash with priorities laid out in the MAHA report.
Kennedy has cited diabetes as part of a crisis in children's health. The $1.4 billion unit the White House has proposed to eliminate at the CDC — the National Center for Chronic Disease Prevention and Health Promotion — has housed a program to track diabetes in children, adolescents, and young adults.
'To say that you want to focus on chronic diseases' and then 'to, for all practical purposes, eliminate the entity at the Centers for Disease Control and Prevention which does chronic diseases,' said Georges Benjamin, executive director of the American Public Health Association, 'obviously doesn't make a lot of sense.'
In a May letter, Office of Management and Budget Director Russell Vought listed the chronic disease center as 'duplicative, DEI, or simply unnecessary,' using an abbreviation for diversity, equity, and inclusion programs.
Within the NIH, the White House has proposed cutting $320 million from the National Institute of Environmental Health Sciences, a reduction of 35%. That unit funds or conducts a wide array of research on issues such as chronic disease.
Trump's budget proposes spending $500 million 'to tackle priority activities to Make America Healthy Again,' including $260 million for his new Administration for a Healthy America to address the 'chronic illness epidemic.'
The MAHA report argues that corporate influence has compromised government agencies and public health through 'corporate capture.'
It alleges that most research on chronic childhood diseases is funded by the food, pharmaceutical, and chemical industries, as well as special interest organizations and professional associations. It says, for example, that a 'significant portion of environmental toxicology and epidemiology studies are conducted by private corporations,' including pesticide manufacturers, and it cites 'potential biases in industry-funded research.'
It's 'self-evident that cutbacks in federal funding leave the field open to the very corporate funding RFK has decried,' said Peter Lurie, president of the Center for Science in the Public Interest, a watchdog group focused on food and health.
Lurie shared the report's concern about industry-funded research but said ceding ground to industry won't help. 'Industry will tend to fund those studies that look to them like they will yield results beneficial to industry,' he said.
In search of new funding sources, Harvard's school of public health 'is now ramping up targeted outreach to potential corporate partners, with careful review to ensure the science meets the highest standards of research integrity,' Andrea Baccarelli, dean of the school's faculty, wrote in a June 11 letter to students, faculty, and others.
'It's just simple math that if you devastate governmental funding by tens of billions of dollars, then the percentage of industry funding dollars will go up,' said Plough, who is also a clinical professor at the University of Washington School of Public Health.
'So therefore, what they claim to fear more,' he said, will 'become even more influential.'
The MAHA report says 'the U.S. government is committed to fostering radical transparency and gold-standard science.'
But many scientists and other scholars see the Trump administration waging a war on science that conflicts with its agenda.
In March, members of the National Academies of Sciences, Engineering, and Medicine accused the administration of 'destroying' scientific independence, 'engaging in censorship,' and 'pressuring researchers to alter or abandon their work on ideological grounds.'
In May, NIH employees wrote that the administration was politicizing research — for example, by halting or censoring work on health disparities, health impacts of climate change, gender identity, and immunizations.
Recent comments by Kennedy pose another threat to transparency, researchers and health advocates say.
Kennedy said on a podcast that he would probably create in-house government journals and stop NIH scientists from publishing their research in The Lancet, The New England Journal of Medicine, The Journal of the American Medical Association, and others.
Creating new government outlets for research would be a plus, said Dariush Mozaffarian, director of the Food is Medicine Institute at the Friedman School of Nutrition Science and Policy at Tufts University.
But confining government scientists to government journals, he said, 'would be a disaster' and 'would basically amount to censorship.'
'That's just not a good idea for science,' Mozaffarian said.
KFF Health News is a national newsroom that produces in-depth journalism about health issues and is one of the core operating programs at KFF — the independent source for health policy research, polling, and journalism.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


CNN
an hour ago
- CNN
Kennedy's anti-vaccine strategy risks forcing shots off market, manufacturers warn
Vaccines Disability issues Federal agencies Donald TrumpFacebookTweetLink Follow Dining under palm trees on a patio at Mar-a-Lago in December, President-elect Donald Trump reassured chief executives at pharmaceutical giants Eli Lilly and Pfizer that anti-vaccine activist Robert F. Kennedy Jr. wouldn't be a radical choice to head the Department of Health and Human Services. 'I think he's going to be much less radical than you would think,' Trump said later that month during a news conference at his Palm Beach, Florida, resort. Eight months have passed, and Kennedy is intensifying his attacks on the vaccine system. High on his list of targets: a federal vaccine compensation program that settles injury claims. His strategy could bankrupt or diminish the fund, some legal scholars and public health leaders say, saddling pharmaceutical companies with liability risks and costs that would compel them to stop making vaccines altogether. 'It's a radical agenda,' said Angela Rasmussen, a virologist at the Vaccine and Infectious Disease Organization at the University of Saskatchewan in Canada. 'He's using a bunch of different mechanisms and there really are no guardrails. People are going to catch on but it's not going to be enough to stop the waves of deaths, and deaths of children.' Kennedy has said changes to the U.S. vaccine system are needed because, he asserts without evidence, immunizations are linked to autism, neurotoxicity, allergies, and death. He is a leader of the 'Make America Healthy Again' movement, an informal campaign that eschews traditional medicine and espouses 'medical freedom.' Many adherents oppose vaccines and believe they are unsafe despite scientific evidence to the contrary. Kennedy has acknowledged he wants to reform the vaccine fund, known as the Vaccine Injury Compensation Program, writing July 28 on the social platform X that 'the VICP is broken, and I intend to fix it.' HHS is working with the Department of Justice to revamp the program, which shields drugmakers from most liability over injuries. HHS didn't respond to a request to speak with Kennedy, but agency officials said he isn't opposed to immunizations. 'Secretary Kennedy is not anti-vaccine — he is pro-safety, pro-transparency, and pro-accountability,' HHS spokesperson Vianca Rodriguez Feliciano said in an email. Yet behind the scenes, Kennedy has been laying the groundwork to restrict the availability of widely used immunizations, according to people familiar with internal discussions who asked not to be identified because they're not authorized to speak on the topic. The strategy began taking shape in the spring. The first step: Raise unfounded questions about the safety of vaccines. At a Cabinet meeting in April, Kennedy told Trump that HHS was undertaking a massive study that would identify the cause of rising autism diagnoses by September. Kennedy tasked David Geier, a researcher who's repeated the debunked claim that vaccines cause autism, to oversee the work, according to media reports. Kennedy then doubled down by questioning the use of aluminum, which is added to many vaccines to help boost the immune response. He linked it to allergies at a July meeting of governors, even though a recent study in the Annals of Internal Medicine found no connection. He's widely expected to ask a federal vaccine advisory committee to conduct a review. The autism research and concerns about aluminum were early salvos in the push to go after the compensation fund, according to two of the people. That fund provides money to people for injuries from vaccines and has paid out more than $5 billion since it was established in 1988, according to the Health Resources and Services Administration. Before filing a lawsuit in court, injured individuals bring their claims to the program's nonjury vaccine court, which reviews evidence. The fund provides compensation from a small excise tax on vaccines. Compensation is determined in part by a table maintained by HRSA and overseen by the HHS secretary. It lists each vaccine and associated injuries and encompasses routine vaccinations recommended by the Centers for Disease Control and Prevention that are subject to the excise tax. The injuries include anaphylaxis and encephalitis. People who experience such injuries within a certain time after getting a specific vaccine can get money. Kennedy wants to get autism or allergies added to that document, according to two people familiar with internal discussions and concerns raised publicly by some vaccine developers and former regulators. He could accomplish the goal if HHS-led research blames vaccines for autism, for example, or if a federal vaccine advisory panel recommends against aluminum in vaccines, according to some legal scholars. 'Given the rate of autism, if a lot of cases are brought, that could bankrupt the program,' said Dorit Reiss, a professor at University of California Law San Francisco. If that were to happen, pharmaceutical companies could stop producing the immunizations, which don't tend to be very profitable, rather than get entangled in drawn-out, expensive lawsuits from claimants who can't get money because the federal vaccine injury fund has run dry, some legal experts and vaccine developers said. 'The compensation fund, if it's gone, would impact decisions to proceed or not to proceed,' said David Dodd, president and CEO of GeoVax Labs, a biotechnology company developing vaccines and immunotherapies. A federal vaccine advisory panel could also recommend against aluminum in shots, forcing drugmakers to make costly reformulations or exit the market. Kennedy has placed people around him to execute the strategy. He's pushed to get vaccine skeptics in decision-making positions at the CDC, which recommends vaccines, and the Food and Drug Administration, which approves them. He also tapped leaders in the anti-vaccine movement to vet candidates for him. The outcome has been regulatory and policy decisions that have winnowed vaccine access and development. HHS this month said it was halting $500 million in grants and contracts for the development of mRNA vaccines, including an improved, more durable covid mRNA vaccine. The federal government stopped recommending covid shots for healthy pregnant women and children, bypassing input from a vaccine advisory committee that traditionally would have weighed in. And Kennedy reconstituted that committee with his own handpicked members, including vaccine skeptics, and removed the American Medical Association, American Nurses Association, and other industry groups that served as committee liaisons. The modified panel recommended against flu vaccines containing a preservative erroneously linked to autism. Kennedy's determination to keep vaccine skeptics in oversight positions played out in a deal he recently made with Trump and his staff, according to two people familiar with the situation. The arrangement came together on a Sunday night in July when Kennedy got a call from the White House. The subject was Vinay Prasad, a top vaccine regulator at the FDA. He had recently touched off a wave of industry criticism for playing a role in the agency's decision to ask biotech company Sarepta Therapeutics to halt shipments of a gene therapy over safety concerns. Social media posts and conservative commentators whipped up a furor. Laura Loomer, a far-right provocateur, said July 21 on X that Prasad should be fired and called him 'a self-proclaimed progressive liberal and Bernie Sanders fanboy,' referring to Sen. Bernie Sanders (I-Vt.). Congressional lawmakers began peppering the White House with questions. The furor reached Trump, who wanted Prasad out, according to the people. But Kennedy was concerned about losing Prasad. He felt he needed a critic of immunizations overseeing vaccines at the agency. So Kennedy struck a deal. Prasad would be asked to resign as head of the FDA's Center for Biologics Evaluation and Research, which regulates vaccine products and biologics such as gene therapies. And the center would be divided into two operations, with Kennedy empowered to select the person overseeing vaccines. Some public health leaders publicly shared details of the arrangement and raised concerns about its potential impact. Former FDA Commissioner Scott Gottlieb said in an Aug. 1 interview on CNBC that he thought it 'would be very destructive to the agency.' After leaving the agency in July, Prasad is now returning, though it is unclear if his role has changed. Recently, Kennedy was sued by Ray Flores, senior outside council for the Children's Health Defense. The Children's Health Defense, an anti-vaccine group founded by Kennedy, is funding the suit, which claims Kennedy failed to launch a task force to study vaccine safety that it says is required to report findings to Congress. But Kennedy and his allies view the lawsuit as friendly, according to one person familiar with the matter, because it is seeking an outcome that he wants. HHS on Aug. 14 announced it was reviving a federal panel, disbanded in 1998, to provide oversight of pediatric vaccines. Kennedy's work against vaccines has triggered unfriendly lawsuits too, including one brought by the American Academy of Pediatrics and other public health groups. His recent decision to halt funds for mRNA vaccine development yielded a swell of social media criticism. 'This is reckless. This is dangerous. This will cost lives. We must fight back,' Sen. Edward Markey (D-Mass.) said Aug. 5 on X. 'I've tried to be objective & non-alarmist in response to current HHS actions – but quite frankly this move is going to cost lives,' Jerome Adams, who was U.S. surgeon general during the previous Trump administration, said Aug. 5 on the same platform. Kennedy and his backers remain undeterred. In a counterpunch, his supporters are launching an unprecedented public relations campaign to promote the HHS secretary, spurring speculation that he may be mulling a 2028 presidential run. The nonprofit MAHA Action held a call in July to energize Kennedy supporters and initiated a six-figure ad campaign extolling Kennedy and Trump administration health initiatives. 'Make no mistake, this is a revolution that will change the face of public health policy,' Tony Lyons, president of MAHA Action, said in a statement. 'Americans are demanding radical transparency and gold standard science.' KFF Health News is a national newsroom that produces in-depth journalism about health issues and is one of the core operating programs at KFF — the independent source for health policy research, polling, and journalism.


CNN
an hour ago
- CNN
Kennedy's anti-vaccine strategy risks forcing shots off market, manufacturers warn
Dining under palm trees on a patio at Mar-a-Lago in December, President-elect Donald Trump reassured chief executives at pharmaceutical giants Eli Lilly and Pfizer that anti-vaccine activist Robert F. Kennedy Jr. wouldn't be a radical choice to head the Department of Health and Human Services. 'I think he's going to be much less radical than you would think,' Trump said later that month during a news conference at his Palm Beach, Florida, resort. Eight months have passed, and Kennedy is intensifying his attacks on the vaccine system. High on his list of targets: a federal vaccine compensation program that settles injury claims. His strategy could bankrupt or diminish the fund, some legal scholars and public health leaders say, saddling pharmaceutical companies with liability risks and costs that would compel them to stop making vaccines altogether. 'It's a radical agenda,' said Angela Rasmussen, a virologist at the Vaccine and Infectious Disease Organization at the University of Saskatchewan in Canada. 'He's using a bunch of different mechanisms and there really are no guardrails. People are going to catch on but it's not going to be enough to stop the waves of deaths, and deaths of children.' Kennedy has said changes to the U.S. vaccine system are needed because, he asserts without evidence, immunizations are linked to autism, neurotoxicity, allergies, and death. He is a leader of the 'Make America Healthy Again' movement, an informal campaign that eschews traditional medicine and espouses 'medical freedom.' Many adherents oppose vaccines and believe they are unsafe despite scientific evidence to the contrary. Kennedy has acknowledged he wants to reform the vaccine fund, known as the Vaccine Injury Compensation Program, writing July 28 on the social platform X that 'the VICP is broken, and I intend to fix it.' HHS is working with the Department of Justice to revamp the program, which shields drugmakers from most liability over injuries. HHS didn't respond to a request to speak with Kennedy, but agency officials said he isn't opposed to immunizations. 'Secretary Kennedy is not anti-vaccine — he is pro-safety, pro-transparency, and pro-accountability,' HHS spokesperson Vianca Rodriguez Feliciano said in an email. Yet behind the scenes, Kennedy has been laying the groundwork to restrict the availability of widely used immunizations, according to people familiar with internal discussions who asked not to be identified because they're not authorized to speak on the topic. The strategy began taking shape in the spring. The first step: Raise unfounded questions about the safety of vaccines. At a Cabinet meeting in April, Kennedy told Trump that HHS was undertaking a massive study that would identify the cause of rising autism diagnoses by September. Kennedy tasked David Geier, a researcher who's repeated the debunked claim that vaccines cause autism, to oversee the work, according to media reports. Kennedy then doubled down by questioning the use of aluminum, which is added to many vaccines to help boost the immune response. He linked it to allergies at a July meeting of governors, even though a recent study in the Annals of Internal Medicine found no connection. He's widely expected to ask a federal vaccine advisory committee to conduct a review. The autism research and concerns about aluminum were early salvos in the push to go after the compensation fund, according to two of the people. That fund provides money to people for injuries from vaccines and has paid out more than $5 billion since it was established in 1988, according to the Health Resources and Services Administration. Before filing a lawsuit in court, injured individuals bring their claims to the program's nonjury vaccine court, which reviews evidence. The fund provides compensation from a small excise tax on vaccines. Compensation is determined in part by a table maintained by HRSA and overseen by the HHS secretary. It lists each vaccine and associated injuries and encompasses routine vaccinations recommended by the Centers for Disease Control and Prevention that are subject to the excise tax. The injuries include anaphylaxis and encephalitis. People who experience such injuries within a certain time after getting a specific vaccine can get money. Kennedy wants to get autism or allergies added to that document, according to two people familiar with internal discussions and concerns raised publicly by some vaccine developers and former regulators. He could accomplish the goal if HHS-led research blames vaccines for autism, for example, or if a federal vaccine advisory panel recommends against aluminum in vaccines, according to some legal scholars. 'Given the rate of autism, if a lot of cases are brought, that could bankrupt the program,' said Dorit Reiss, a professor at University of California Law San Francisco. If that were to happen, pharmaceutical companies could stop producing the immunizations, which don't tend to be very profitable, rather than get entangled in drawn-out, expensive lawsuits from claimants who can't get money because the federal vaccine injury fund has run dry, some legal experts and vaccine developers said. 'The compensation fund, if it's gone, would impact decisions to proceed or not to proceed,' said David Dodd, president and CEO of GeoVax Labs, a biotechnology company developing vaccines and immunotherapies. A federal vaccine advisory panel could also recommend against aluminum in shots, forcing drugmakers to make costly reformulations or exit the market. Kennedy has placed people around him to execute the strategy. He's pushed to get vaccine skeptics in decision-making positions at the CDC, which recommends vaccines, and the Food and Drug Administration, which approves them. He also tapped leaders in the anti-vaccine movement to vet candidates for him. The outcome has been regulatory and policy decisions that have winnowed vaccine access and development. HHS this month said it was halting $500 million in grants and contracts for the development of mRNA vaccines, including an improved, more durable covid mRNA vaccine. The federal government stopped recommending covid shots for healthy pregnant women and children, bypassing input from a vaccine advisory committee that traditionally would have weighed in. And Kennedy reconstituted that committee with his own handpicked members, including vaccine skeptics, and removed the American Medical Association, American Nurses Association, and other industry groups that served as committee liaisons. The modified panel recommended against flu vaccines containing a preservative erroneously linked to autism. Kennedy's determination to keep vaccine skeptics in oversight positions played out in a deal he recently made with Trump and his staff, according to two people familiar with the situation. The arrangement came together on a Sunday night in July when Kennedy got a call from the White House. The subject was Vinay Prasad, a top vaccine regulator at the FDA. He had recently touched off a wave of industry criticism for playing a role in the agency's decision to ask biotech company Sarepta Therapeutics to halt shipments of a gene therapy over safety concerns. Social media posts and conservative commentators whipped up a furor. Laura Loomer, a far-right provocateur, said July 21 on X that Prasad should be fired and called him 'a self-proclaimed progressive liberal and Bernie Sanders fanboy,' referring to Sen. Bernie Sanders (I-Vt.). Congressional lawmakers began peppering the White House with questions. The furor reached Trump, who wanted Prasad out, according to the people. But Kennedy was concerned about losing Prasad. He felt he needed a critic of immunizations overseeing vaccines at the agency. So Kennedy struck a deal. Prasad would be asked to resign as head of the FDA's Center for Biologics Evaluation and Research, which regulates vaccine products and biologics such as gene therapies. And the center would be divided into two operations, with Kennedy empowered to select the person overseeing vaccines. Some public health leaders publicly shared details of the arrangement and raised concerns about its potential impact. Former FDA Commissioner Scott Gottlieb said in an Aug. 1 interview on CNBC that he thought it 'would be very destructive to the agency.' After leaving the agency in July, Prasad is now returning, though it is unclear if his role has changed. Recently, Kennedy was sued by Ray Flores, senior outside council for the Children's Health Defense. The Children's Health Defense, an anti-vaccine group founded by Kennedy, is funding the suit, which claims Kennedy failed to launch a task force to study vaccine safety that it says is required to report findings to Congress. But Kennedy and his allies view the lawsuit as friendly, according to one person familiar with the matter, because it is seeking an outcome that he wants. HHS on Aug. 14 announced it was reviving a federal panel, disbanded in 1998, to provide oversight of pediatric vaccines. Kennedy's work against vaccines has triggered unfriendly lawsuits too, including one brought by the American Academy of Pediatrics and other public health groups. His recent decision to halt funds for mRNA vaccine development yielded a swell of social media criticism. 'This is reckless. This is dangerous. This will cost lives. We must fight back,' Sen. Edward Markey (D-Mass.) said Aug. 5 on X. 'I've tried to be objective & non-alarmist in response to current HHS actions – but quite frankly this move is going to cost lives,' Jerome Adams, who was U.S. surgeon general during the previous Trump administration, said Aug. 5 on the same platform. Kennedy and his backers remain undeterred. In a counterpunch, his supporters are launching an unprecedented public relations campaign to promote the HHS secretary, spurring speculation that he may be mulling a 2028 presidential run. The nonprofit MAHA Action held a call in July to energize Kennedy supporters and initiated a six-figure ad campaign extolling Kennedy and Trump administration health initiatives. 'Make no mistake, this is a revolution that will change the face of public health policy,' Tony Lyons, president of MAHA Action, said in a statement. 'Americans are demanding radical transparency and gold standard science.' KFF Health News is a national newsroom that produces in-depth journalism about health issues and is one of the core operating programs at KFF — the independent source for health policy research, polling, and journalism.


Time Magazine
2 hours ago
- Time Magazine
Chatbots Can Trigger a Mental Health Crisis. What to Know About 'AI Psychosis'
The Brief August 6, 2025 Trump threatens to federalize D.C., New York's Legionnaires' disease outbreak, and more Length: Long Speed: 1.0x AI chatbots have become a ubiquitous part of life. People turn to tools like ChatGPT, Claude, Gemini, and Copilot not just for help with emails, work, or code, but for relationship advice, emotional support, and even friendship or love. But for a minority of users, these conversations appear to have disturbing effects. A growing number of reports suggest that extended chatbot use may trigger or amplify psychotic symptoms in some people. The fallout can be devastating and potentially lethal. Users have linked their breakdowns to lost jobs, fractured relationships, involuntary psychiatric holds, and even arrests and jail time. At least one support group has emerged for people who say their lives began to spiral after interacting with AI. The phenomenon—sometimes colloquially called 'ChatGPT psychosis' or 'AI psychosis'—isn't well understood. There's no formal diagnosis, data are scarce, and no clear protocols for treatment exist. Psychiatrists and researchers say they're flying blind as the medical world scrambles to catch up. What is 'ChatGPT psychosis' or 'AI psychosis'? The terms aren't formal ones, but they have emerged as shorthand for a concerning pattern: people developing delusions or distorted beliefs that appear to be triggered or reinforced by conversations with AI systems. Psychosis may actually be a misnomer, says Dr. James MacCabe, a professor in the department of psychosis studies at King's College London. The term usually refers to a cluster of symptoms—disordered thinking, hallucinations, and delusions—often seen in conditions like bipolar disorder and schizophrenia. But in these cases, 'we're talking about predominantly delusions, not the full gamut of psychosis.' Read More: How to Deal With a Narcissist The phenomenon seems to reflect familiar vulnerabilities in new contexts, not a new disorder, psychiatrists say. It's closely tied to how chatbots communicate; by design, they mirror users' language and validate their assumptions. This sycophancy is a known issue in the industry. While many people find it irritating, experts warn it can reinforce distorted thinking in people who are more vulnerable. Who's most at risk? While most people can use chatbots without issue, experts say a small group of users may be especially vulnerable to delusional thinking after extended use. Some media reports of AI psychosis note that individuals had no prior mental health diagnoses, but clinicians caution that undetected or latent risk factors may still have been present. 'I don't think using a chatbot itself is likely to induce psychosis if there's no other genetic, social, or other risk factors at play,' says Dr. John Torous, a psychiatrist at the Beth Israel Deaconess Medical Center. 'But people may not know they have this kind of risk.' The clearest risks include a personal or family history of psychosis, or conditions like schizophrenia or bipolar disorder. Read More: ChatGPT May Be Eroding Critical Thinking Skills, According to a New MIT Study Those with personality traits that make them susceptible to fringe beliefs may also be at risk, says Dr. Ragy Girgis, a professor of clinical psychiatry at Columbia University. Such individuals may be socially awkward, struggle with emotional regulation, and have an overactive fantasy life, Girgis says. Immersion matters, too. 'Time seems to be the single biggest factor,' says Stanford psychiatrist Dr. Nina Vasan, who specializes in digital mental health. 'It's people spending hours every day talking to their chatbots.' What people can do to stay safe Chatbots aren't inherently dangerous, but for some people, caution is warranted. First, it's important to understand what large language models (LLMs) are and what they're not. 'It sounds silly, but remember that LLMs are tools, not friends, no matter how good they may be at mimicking your tone and remembering your preferences,' says Hamilton Morrin, a neuropsychiatrist at King's College London. He advises users to avoid oversharing or relying on them for emotional support. Psychiatrists say the clearest advice during moments of crisis or emotional strain is simple: stop using the chatbot. Ending that bond can be surprisingly painful, like a breakup or even a bereavement, says Vasan. But stepping away can bring significant improvement, especially when users reconnect with real-world relationships and seek professional help. Recognizing when use has become problematic isn't always easy. 'When people develop delusions, they don't realize they're delusions. They think it's reality,' says MacCabe. Read More: Are Personality Tests Actually Useful? Friends and family also play a role. Loved ones should watch for changes in mood, sleep, or social behavior, including signs of detachment or withdrawal. 'Increased obsessiveness with fringe ideologies' or 'excessive time spent using any AI system' are red flags, Girgis says. Dr. Thomas Pollak, a psychiatrist at King's College London, says clinicians should be asking patients with a history of psychosis or related conditions about their use of AI tools, as part of relapse prevention. But those conversations are still rare. Some people in the field still dismiss the idea of AI psychosis as scaremongering, he says. What AI companies should be doing So far, the burden of caution has mostly fallen on users. Experts say that needs to change. One key issue is the lack of formal data. Much of what we know about ChatGPT psychosis comes from anecdotal reports or media coverage. Experts widely agree that the scope, causes, and risk factors are still unclear. Without better data, it's hard to measure the problem or design meaningful safeguards. Many argue that waiting for perfect evidence is the wrong approach. 'We know that AI companies are already working with bioethicists and cyber-security experts to minimize potential future risks,' says Morrin. 'They should also be working with mental-health professionals and individuals with lived experience of mental illness.' At a minimum, companies could simulate conversations with vulnerable users and flag responses that might validate delusions, Morrin says. Some companies are beginning to respond. In July, OpenAI said it has hired a clinical psychiatrist to help assess the mental-health impact of its tools, which include ChatGPT. The following month, the company acknowledged times its 'model fell short in recognizing signs of delusion or emotional dependency.' It said it would start prompting users to take breaks during long sessions, develop tools to detect signs of distress, and tweak ChatGPT's responses in 'high-stakes personal decisions.' Others argue that deeper changes are needed. Ricardo Twumasi, a lecturer in psychosis studies at King's College London, suggests building safeguards directly into AI models before release. That could include real-time monitoring for distress or a 'digital advance directive' allowing users to pre-set boundaries when they're well. Read More: How to Find a Therapist Who's Right for You Dr. Joe Pierre, a psychiatrist at the University of California, San Francisco, says companies should study who is being harmed and in what ways, and then design protections accordingly. That might mean nudging troubling conversations in a different direction or issuing something akin to a warning label. Vasan adds that companies should routinely probe their systems for a wide range of mental-health risks, a process known as red-teaming. That means going beyond tests for self-harm and deliberately simulating interactions involving conditions like mania, psychosis, and OCD to assess how the models respond. Formal regulation may be premature, experts say. But they stress that companies should still hold themselves to a higher standard. Chatbots can reduce loneliness, support learning, and aid mental health. The potential is vast. But if harms aren't taken as seriously as hopes, experts say, that potential could be lost. 'We learned from social media that ignoring mental-health harm leads to devastating public-health consequences,' Vasan says. 'Society cannot repeat that mistake.'